Cancer Research Cancer Epigenetics  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 6549-6553, October 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dagnino, L.
Right arrow Articles by Paterson, A. R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dagnino, L.
Right arrow Articles by Paterson, A. R. P.

Sodium-dependent and Equilibrative Nucleoside Transport Systems in L1210 Mouse Leukemia Cells: Effect of Inhibitors of Equilibrative Systems on the Content and Retention of Nucleosides1

Lina Dagnino2 and Alan R. P. Paterson3

Cancer Research Group (McEachern Laboratory) and Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7

The presence of 10 µM dipyridamole in incubation media of L1210/C2 cells decreased initial rates of zero-trans influx of formycin B (FB, 50 µM), a poorly metabolized inosine analogue, from 4.84 pmol/µl cell water/s to 0.87 pmol/µl cell water/s. However, after a 5-min interval of uptake, free FB levels in dipyridamole-treated cells were 165 pmol/µl cell water, 2.3-fold greater than in dipyridamole-free cultures. This indicated the presence of a concentrative, dipyridamole-insensitive nucleoside transport (NT) system in L1210 cells, in addition to the equilibrative NT systems known to be expressed in these cells. The concentrative system was demonstrable only in the presence of NT inhibitors and required extracellular Na+. The presence of 8 µM 6-[(4-nitrobenzyl)thio]-9-ß-D-ribofuranosylpurine or 15 µM dilazep also induced an accumulation of free FB above steady-state levels, although of a lesser magnitude than that observed with dipyridamole. It appears that NT inhibitors induced nucleoside accumulation by inhibiting bidirectional nucleoside movements mediated by the equilibrative component of nucleoside transport in L1210/C2 cells without interfering with inward FB fluxes mediated by the Na+-dependent transporter. The presence of NT inhibitors also enhanced the cellular accumulation and retention of arabinosyladenine and its 5'-triphosphate in these cells. The increased cellular accumulation of 9-ß-D-arabinofuranosyladenine and 9-ß-D-arabinofuranosyladenine triphosphate by dipyridamole was associated with enhanced antiproliferative activity of 9-ß-D-arabinofuranosyladenine towards the leukemia cells.

1 This study was supported by the National Cancer Institute of Canada.

2 Recipient of a Studentship award from the Alberta Heritage Foundation for Medical Research. Present address: Institut de Recherches Cliniques de Montréal, 110 Avenue des Pins Ouest, Montréal, Québec, Canada H2W 1R7.

3 Senior Research Scientist of the National Cancer Institute of Canada. To whom requests for reprints should be addressed, at Department of Pharmacology, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada.

Received 9/11/87. Accepted 7/12/90.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. T. Lang, M. Selner, J. D. Young, and C. E. Cass
Acquisition of Human Concentrative Nucleoside Transporter 2 (hCNT2) Activity by Gene Transfer Confers Sensitivity to Fluoropyrimidine Nucleosides in Drug-Resistant Leukemia Cells
Mol. Pharmacol., November 1, 2001; 60(5): 1143 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Burke, S. Lee, P. J. Ferguson, and J. R. Hammond
Interaction of 2',2'-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1333 - 1340.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Y. M. Yao, A. M. L. Ng, W. R. Muzyka, M. Griffiths, C. E. Cass, S. A. Baldwin, and J. D. Young
Molecular Cloning and Functional Characterization of Nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) Equilibrative Nucleoside Transporter Proteins (rENT1 and rENT2) from Rat Tissues
J. Biol. Chem., November 7, 1997; 272(45): 28423 - 28430.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Borgl and a. F. E. Parkinson
Uptake and Release of [3H]Formycin B via Sodium-Dependent Nucleoside Transporters in Mouse Leukemic L1210/MA27.1 Cells
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 347 - 353.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.